Expression of heterologous genes in oncolytic adenoviruses using picornaviral 2A sequences that trigger ribosome skipping

Journal of General Virology

Volumn 89, Issue 2, 2008, Pages 389-396

  Funston, Garth M ^a   Kallioinen, Susanna E ^a   de Felipe, Pablo ^a   Ryan, Martin D ^b   Iggo, Richard D ^a  

^a UNIVERSITY OF ST ANDREWS   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS PROTEIN IX; CAPSID PROTEIN; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; ONCOLYTIC ADENOVIRUS; CYSTEINE PROTEINASE; ONCOLYTIC VIRUS; PICORNAIN 2A, PICORNAVIRUS; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

ADENOVIRUS 5; ARTICLE; CELL STRAIN HT29; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; EXPRESSION VECTOR; FOOT AND MOUTH DISEASE VIRUS; GENE INSERTION; GENOMIC INSTABILITY; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; OPEN READING FRAME; PICORNAVIRUS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RIBOSOME; SEQUENCE ANALYSIS; TESCHOVIRUS; VIRUS GENE; VIRUS PLAQUE; ADENOVIRUS; ANIMAL; BIOSYNTHESIS; GENETICS; METABOLISM; PROTEIN PROCESSING;

FOOT-AND-MOUTH DISEASE VIRUS; HUMAN ADENOVIRUS TYPE 5; MIRIDAE; PERU TOMATO MOSAIC VIRUS; PORCINE TESCHOVIRUS 1;

ADENOVIRIDAE; ANIMALS; CYSTEINE ENDOPEPTIDASES; FOOT-AND-MOUTH DISEASE VIRUS; GREEN FLUORESCENT PROTEINS; HUMANS; ONCOLYTIC VIRUSES; PICORNAVIRIDAE; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; RIBOSOMES; RNA, VIRAL; VIRAL PROTEINS;

EID: 41649107151     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83444-0     Document Type: Article

References (32)

1. Alemany, R. (2007). Cancer selective adenoviruses. Mol Aspects Med 28, 42-58.
2. Amalfitano, A. & Chamberlain, J. S. (1997). Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy. Gene Ther 4, 258-263.
3. Caravokyri, C. & Leppard, K. N. (1995). Constitutive episomal expression of polypeptide IX (pIX) in a 293-based cell line complements the deficiency of pIX mutant adenovirus type 5. J Virol 69, 6627-6633.
4. de Felipe, P. (2002). Polycistronic viral vectors. Curr Gene Ther 2, 355-378.
5. de Felipe, P. & Izquierdo, M. (2000). Tricistronic and tetracistronic retroviral vectors for gene transfer. Hum Gene Ther 11, 1921-1931.
6. de Felipe, P. & Izquierdo, M. (2003). Construction and characterization of pentacistronic retrovirus vectors. J Gen Virol 84, 1281-1285.
7. de Felipe, P., Luke, G. A., Hughes, L. E., Gani, D., Halpin, C. & Ryan, M. D. (2006). E unum pluribus: multiple proteins from a self-processing polyprotein. Trends Biotechnol 24, 68-75.
8. Dmitriev, I. P., Kashentseva, E. A. & Curiel, D. T. (2002). Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX. J Virol 76, 6893-6899.
9. Donnelly, M. L., Hughes, L. E., Luke, G., Mendoza, H., ten Dam, E., Gani, D. & Ryan, M. D. (2001). The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. J Gen Virol 82, 1027-1041.
10. Fallaux, F. J., Kranenburg, O., Cramer, S. J., Houweling, A., Van Ormondt, H., Hoeben, R. C. & Van Der Eb, A. J. (1996). Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum Gene Ther 7, 215-222.
11. Fuerer, C. & Iggo, R. (2004). 5-Fluorocytosine increases the toxicity of Wnt-targeting replicating adenoviruses that express cytosine deaminase as a late gene. Gene Ther 11, 142-151.
12. Furcinitti, P. S., van Oostrum, J. & Burnett, R. M. (1989). Adenovirus polypeptide IX revealed as capsid cement by difference images from electron microscopy and crystallography. EMBO J 8, 3563-3570.
13. Gagnebin, J., Brunori, M., Otter, M., Juillerat-Jeanneret L., Monnier, P. & Iggo, R. (1999). A photosensitising adenovirus for photodynamic therapy. Gene Ther 6, 1742-1750.
14. Ghosh-Choudhury, G., Haj-Ahmad, Y. & Graham, F. L. (1987). Protein IX, a minor component of the human adenovirus capsid, is essential for the packaging of full length genomes. EMBO J 6, 1733-1739.
15. Holst J., Vignall, K. M., Burton, A. R. & Vignali, D. A. (2006). Rapid analysis of T-cell selection in vivo using T cell-receptor retrogenic mice. Nat Methods 3, 191-197.
16. Homicsko, K., Lukashev, A. & Iggo, R. D. (2005). RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer. Cancer Res 65, 6882-6890.
17. Le, L. P., Everts, M., Dmitriev, I. P., Davydova, J. G., Yamamoto M. & Curiel, D. T. (2004). Fluorescently labeled adenovirus with pIX-EGFP for vector detection. Mol Imaging 3, 105-116.
18. Li, J., Le, L., Sibley, D. A., Mathis, J. M. & Curiel, D. T. (2005). Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion. Virology 338, 247-258.
19. Lukashev, A. N., Fuerer, C., Chen, M. J., Searle, P. & Iggo, R. (2005). Late expression of nitroreductase in an oncolytic adenovirus sensitizes colon cancer cells to the prodrug CB1954. Hum Gene Ther 16, 1473-1483.
20. Meulenbroek, R. A., Sargent, K. L., Lunde, J., Jasmin, B. J. & Parks, R. J. (2004). Use of adenovirus protein IX (pIX) to display large polypeptides on the virion-generation of fluorescent virus through the incorporation of pIX-GFP. Mol Ther 9, 617-624.
21. Parks, R. J. (2005). Adenovirus protein IX: a new look at an old protein. Mol Ther 11, 19-25.
22. Rosa-Calatrava, M., Grave, L., Puvion-Dutilleul, F., Chatton, B. & Kedinger, C. (2001). Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear, reorganization. J Virol 75, 7131-7141.
23. Rosa-Calatrava, M., Puvion-Dutilleul, F., Lutz, P., Dreyer, D., de The, H., Chatton, B. & Kedinger, C. (2003). Adenovirus protein IX sequesters host-cell promyelocytic leukaemia protein and contributes to efficient viral proliferation. EMBO Rep 4, 969-975.
24. Ryan, M. D. & Drew, J. (1994). Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. EMBO J 13, 928-933.
25. Sargent, K. L., Meulenbroek, R. A. & Parks, R. J. (2004a). Activation of adenoviral gene expression by protein IX is not required for efficient virus replication. J Virol 78, 5032-5037.
26. Sargent, K. L., Ng, P., Evelegh, C., Graham, F. L. & Parks, R. J. (2004b). Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors. Gene Ther 11, 504-511.
27. Sikorski, R. S. & Hieter, P. (1989). A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 122, 19-27.
28. Vellinga, J., Rabelink M. J., Cramer, S. J., von den Wollenberg, D. J., Van der Meulen, H., Leppard, K. N., Fallaux, F. J. & Hoeben, R. C. (2004). Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX. J Virol 78, 3470-3479.
29. Vellinga, J., van den Wollenberg, D. J., van der Heijdt S., Rabelink, M. J. & Hoeben, R. C. (2005a). The coiled-coil domain of the adenovirus type 5 protein IX is dispensable for capsid incorporation and thermostability. J Virol 79, 3206-3210.
30. Vellinga, J., Van der Heijdt, S. & Hoeben, R. C. (2005b). The adenovirus capsid: major progress in minor proteins. J Gen Virol 86, 1581-1588.
31. Vellinga, J., Uil, T. G., de Vrij, J., Rabelink, M. J., Lindholm, L. & Hoeben, R. C. (2006). A system for efficient generation of adenovirus protein IX-producing helper cell lines. J Gene Med 8, 147-154.
32. Vellinga, J., de Vrij, J., Myhre, S, Uil, T., Martineau, P., Lindholm, L. & Hoeben, R. C. (2007). Efficient incorporation of a functional hyperstable single-chain antibody fragment protein-IX fusion in the adenovirus capsid. Gene Ther. 14, 664-670.